Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | GAA | P10253 | 2/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.69 |
| ▸ | GLA | P06280 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | RAB9A | P51151 | 4/20 | 0.67 |
| ▸ | NPC1 | O15118 | 3/20 | 0.67 |
| ▸ | HPGD | P15428 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | POLB | P06746 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | CASP1 | P29466 | 1/20 | 0.67 |
| ▸ | CASP7 | P55210 | 1/20 | 0.67 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.67 |
| ▸ | RELA | Q04206 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4280023 | 1.00 | ALDH1A1 (0.69) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL1761399 | 0.98 | ALDH1A1 (0.71) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL27816591 | 0.86 | RAB9A (0.69) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL7870469 | 0.85 | ALDH1A1 (0.89) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL2615879 | 0.84 | MEN1 (0.63) | ALDH1A1KDM4EGAARAB9AHPGD | |
| SCHEMBL2615881 | 0.84 | MEN1 (0.63) | ALDH1A1KDM4EGAARAB9AHPGD | |
| SCHEMBL14854089 | 0.84 | ALDH1A1 (0.67) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL8572753 | 0.84 | ALDH1A1 (0.96) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL498669 | 0.84 | ALDH1A1 (0.67) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL20181377 | 0.84 | ALDH1A1 (0.96) | ALDH1A1KDM4ELMNAGAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2379109-B1 | COMBINATION OF PHOTODYNAMIC THERAPY AND ANTI-VEGF AGENTS IN THE TREATMENT OF UNWANTED CHOROIDAL NEOVASCULATURE | BAUSCH HEALTH COMPANIES INC (CA) | 2020-10-07 | — | — | EP | disclosed |
| US-20200290033-A1 | FUNCTIONALIZED ZINC OXIDE NANOPARTICLES FOR PHOTOCATALYTIC WATER SPLITTING | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2020-09-17 | — | — | US | disclosed |
| US-10717072-B2 | Functionalized zinc oxide nanoparticles for photocatalytic water splitting | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2020-07-21 | — | — | US | disclosed |
| US-20160318010-A1 | FUNCTIONALIZED ZINC OXIDE NANOPARTICLES FOR PHOTOCATALYTIC WATER SPLITTING | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-11-03 | — | — | US | disclosed |
| US-20160318010-A1 | FUNCTIONALIZED ZINC OXIDE NANOPARTICLES FOR PHOTOCATALYTIC WATER SPLITTING | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-11-03 | — | — | US | disclosed |
| US-20160318010-A1 | FUNCTIONALIZED ZINC OXIDE NANOPARTICLES FOR PHOTOCATALYTIC WATER SPLITTING | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-11-03 | — | — | US | disclosed |
| EP-3083491-A1 | FUNCTIONALIZED ZINC OXIDE NANOPARTICLES FOR PHOTOCATALYTIC WATER SPLITTING | Council of Scientific and Industrial Research (IN) | 2016-10-26 | — | — | EP | disclosed |
| US-9226917-B2 | Photodynamic therapy for conditions of the eye | VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 2016-01-05 | — | — | US | disclosed |
| WO-2015092816-A1 | FUNCTIONALIZED ZINC OXIDE NANOPARTICLES FOR PHOTOCATALYTIC WATER SPLITTING | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015092816-A1 | FUNCTIONALIZED ZINC OXIDE NANOPARTICLES FOR PHOTOCATALYTIC WATER SPLITTING | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-06-25 | — | — | WO | disclosed |
| US-20020061330-A1 | Supports for photosensitizer formulations | BRITISH COLUMBIA, THE UNIVERSITY OF (CA) | 2002-05-23 | — | — | US | disclosed |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | QLT INC. (CA) | 2002-02-21 | — | — | US | disclosed |
| WO-2001085213-A2 | SUPPORTS FOR PHOTOSENSITIZER FORMULATIONS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001085212-A2 | DRUG DELIVERY SYSTEMS FOR PHOTODYNAMIC THERAPY | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001035996-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| US-5753692-A | PLANT EXTRACTS, IMMUNOSTIMULANTS TREATING IMMUNODEFICIENCY DISEASES | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1998-05-19 | — | — | US | disclosed |
| US-5747525-A | ANTITUMOR AGENTS OF OLIGOMERS OF THIOPHENE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1998-05-05 | — | — | US | disclosed |
| US-5602170-A | ADMINISTERING ANTIIFLAMMATORY AGENT | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1997-02-11 | — | — | US | disclosed |
| US-5180838-A | Terthienyl compounds as insecticides | HER MAJESTY THE QUEEN AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENSE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 1993-01-19 | — | — | US | disclosed |
| US-5045563-A | Terthienyl Compound | HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 1991-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061330-A1 | Supports for photosensitizer formulations | PPOX, PPIF, SDHA | ALDH1A1 371/4885KDM4E 3097/4885LMNA 3268/4885 |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | CD74, ANXA11, ANXA1 | ALDH1A1 794/4885KDM4E 4361/4885LMNA 4877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.